Literature DB >> 21771767

Biogenic monoamines in preimplantation development.

Stefan Cikos1, Dusan Fabian, Alexander V Makarevich, Peter Chrenek, Juraj Koppel.   

Abstract

BACKGROUND: The involvement of biogenic monoamines in early ('preneural') embryogenesis has been well documented in lower vertebrates, but much less information is available about the role of these molecules in the earliest stages of development in mammals, including humans.
METHODS: Databases (PubMed, ISI Web of Knowledge and Scopus) were searched for studies relating to biogenic monoamines functioning in early embryos. The available data on the expression of histamine, serotonin and adrenergic receptors during mammalian preimplantation development were summarized, and the potential roles of biogenic monoamines in very early pregnancy were discussed.
RESULTS: The roles of biogenic monoamines in mammalian preimplantation embryo development can be diverse, depending on the embryo developmental stage, and the physiological status of the maternal organism. Several receptors for biogenic monoamines are expressed and biologically functional in cells of preimplantation embryos. Activation of histamine receptors can play a role in embryo implantation and trophoblast invasion. Activation of adrenergic and serotonin receptors can influence proliferation and survival of early embryonic cells.
CONCLUSIONS: Biogenic monoamines can play an important role in physiological conditions, contributing to embryo-maternal interactions, or can influence the early embryo under unfavorable or pathological conditions (e.g. in maternal stress, or in women taking certain antidepressants, anti-migraine or anti-ulcer drugs).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771767     DOI: 10.1093/humrep/der233

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Successful Pregnancy in a Patient with L-Amino Acid Decarboxylase Deficiency: Therapeutic Management and Clinical Outcome.

Authors:  Mario Mastrangelo; Filippo Manti; Luisa Patanè; Stefania Ferrari; Carla Carducci; Claudia Carducci; Giovanna Mangili; Vincenzo Leuzzi
Journal:  Mov Disord Clin Pract       Date:  2018-05-12

3.  Ginsenoside rb1 modulates level of monoamine neurotransmitters in mice frontal cortex and cerebellum in response to immobilization stress.

Authors:  Sang Hee Lee; Jinyoung Hur; Eunjoo H Lee; Sun Yeou Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-09       Impact factor: 4.634

4.  The effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta.

Authors:  Helena Kaihola; Jocelien Olivier; Inger Sundström Poromaa; Helena Åkerud
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

5.  Adrenergic DNA damage of embryonic pluripotent cells via β2 receptor signalling.

Authors:  Fan Sun; Xu-Ping Ding; Shi-Min An; Ya-Bin Tang; Xin-Jie Yang; Lin Teng; Chun Zhang; Ying Shen; Hong-Zhuan Chen; Liang Zhu
Journal:  Sci Rep       Date:  2015-10-30       Impact factor: 4.379

6.  The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study.

Authors:  Åsa Edvinsson; Charlotte Hellgren; Theodora Kunovac Kallak; Helena Åkerud; Alkistis Skalkidou; Elisabet Stener-Victorin; Romina Fornes; Olav Spigset; Susanne Lager; Jocelien Olivier; Inger Sundström-Poromaa
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-05       Impact factor: 3.007

7.  Atlas of receptor genes expressed by the bovine morula and corresponding ligand-related genes expressed by uterine endometrium.

Authors:  Lei Sang; Yao Xiao; Zongliang Jiang; Niamh Forde; Xiuchun Cindy Tian; Patrick Lonergan; Peter J Hansen
Journal:  Mol Reprod Dev       Date:  2021-10-01       Impact factor: 2.812

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.